» Articles » PMID: 17216257

Normative Data on the Bonn Risk Index for Calcium Oxalate Crystallization in Healthy Children

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2007 Jan 12
PMID 17216257
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Bonn Risk Index (BRI) is being used for the assessment of urinary calcium oxalate (CaOx) crystallization. There are no published data regarding BRI during growth. The objective of this study was to establish age- and sex-dependent BRI values in healthy children and adolescents. A total of 1,050 Caucasian subjects aged 3-18 years (525 males, 525 females) without a history of kidney stone disease were enrolled in the cross-sectional study. The study group was divided into 15 ranges according to age, each comprising 70 subjects. Urinary ionized calcium [Ca2+] was measured using a selective electrode while the onset of spontaneous crystallization was determined using a photometer and titrating with 40 mmol/L ammonium oxalate (Ox(2-)). The calculation of BRI value was based on the ratio of [Ca2+] to the required amount of ammonium oxalate added to 200 ml of urine to induce crystallization. The median BRI was 0.26 1/L and the values of the 5th and 95th percentiles were 0.06 1/L and 1.93 1/L, respectively. BRI correlated positively with body-area-related BRI (1/L x 1.73 m2) (R = 0.18; P < 0.05), whereas a negative correlation was found between BRI and body weight (1/L x kg) (R = -0.85; P < 0.05). Neither sex nor age differences were detected in BRI across studied children and adolescents. The values of Bonn Risk Index were constant during growth and there was a limited influence of age and sex on BRI in children over 3 years of age. The BRI may be valuable in the evaluation of pediatric patients at risk for kidney stones, particularly if the BRI from stone formers is demonstrated to be higher than in normal children.

Citing Articles

Kinetics of calcium oxalate crystal formation in urine.

Laube N, Klein F, Bernsmann F Urolithiasis. 2016; 45(2):151-157.

PMID: 27328814 DOI: 10.1007/s00240-016-0900-y.


Urinary citrate excretion in healthy children depends on age and gender.

Kirejczyk J, Porowski T, Konstantynowicz J, Kozerska A, Nazarkiewicz A, Hoppe B Pediatr Nephrol. 2014; 29(9):1575-82.

PMID: 24696006 PMC: 4147207. DOI: 10.1007/s00467-014-2806-7.


Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.

Porowski T, Kirejczyk J, Konstantynowicz J, Kazberuk A, Plonski G, Wasilewska A Pediatr Nephrol. 2013; 28(7):1079-84.

PMID: 23377289 PMC: 3661906. DOI: 10.1007/s00467-013-2420-0.


Evaluation of pediatric nephrolithiasis.

Kokorowski P, Hubert K, Nelson C Indian J Urol. 2011; 26(4):531-5.

PMID: 21369386 PMC: 3034062. DOI: 10.4103/0970-1591.74453.


Spontaneous urinary calcium oxalate crystallization in hypercalciuric children.

Porowski T, Konstantynowicz J, Zoch-Zwierz W, Kirejczyk J, Taranta-Janusz K, Korzeniecka-Kozerska A Pediatr Nephrol. 2009; 24(9):1705-10.

PMID: 19350280 DOI: 10.1007/s00467-009-1171-4.


References
1.
Laube N, Hergarten S . Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?. J Urol. 2005; 173(6):2175-7. DOI: 10.1097/01.ju.0000158128.21188.ff. View

2.
Kok D . Clinical implications of physicochemistry of stone formation. Endocrinol Metab Clin North Am. 2002; 31(4):855-67. DOI: 10.1016/s0889-8529(02)00037-3. View

3.
Ricchiuti V, Hartke D, Yang L, Goldman H, Elder J, Resnick M . Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int. 2002; 90(6):513-7. DOI: 10.1046/j.1464-410x.2002.02984.x. View

4.
Kraus S, Lebowitz R, Royal S . Renal calculi in children: imaging features that lead to diagnoses: a pictorial essay. Pediatr Radiol. 1999; 29(8):624-30. DOI: 10.1007/s002470050663. View

5.
Laube N, Hergarten S, Hesse A . Comparison of laser-probe and photometric determination of the urinary crystallization risk of calcium oxalate. Clin Chem Lab Med. 2002; 40(6):595-9. DOI: 10.1515/CCLM.2002.102. View